More on amln
Data
Financials
News
|
Amylin Pharmaceuticals, Inc. (NQ:AMLN)
Delayed: 30.98
--0 (-0%)
|
Trade Now! |
|
| Previous Close |
$30.98 |
|
52 Week High |
$31.02 |
|
| Open |
$3.30 |
|
52 Week Low |
$8.03 |
| Day High |
$30.98 |
|
P/E |
N/A |
| Day Low |
$30.98 |
|
EPS |
$-4.38 |
| Volume |
440,704 |
|
|
|
-
Aug 1, 2012 07:34 AM
Bristol-Myers Squibb (BMY) Reports Waiting Period to Acquire Amylin Pharmaceuticals (AMLN) Expired
-
Jul 10, 2012 07:33 AM
Bristol-Myers Squibb (BMY) Commences $31/Share Cash Tender for Amylin (AMLN)
-
Jul 10, 2012 07:16 AM
Stocks with implied volatility movement; AMLN CVS
-
Jul 9, 2012 07:46 AM
Stocks with implied volatility below IV index mean; AMLN LNCR
-
Jul 6, 2012 04:26 PM
Top 10 News Items 7/2-7/6: Private Sector Showed Slowest Pace of Job Growth in 10 Months; Central Banks React; Mergers Get Serious on Monday
-
Jul 6, 2012 07:05 AM
Stocks with implied volatility below IV index mean; AMLN LNCR
-
Jul 3, 2012 06:49 AM
Morgan Stanley Upgrades Amylin Pharmaceuticals (AMLN) to Equalweight
-
Jul 2, 2012 05:13 PM
Market Wrap: US Manufacturing Hits the Skids; Apple Settles 'iPad' Suit; Merger Monday!
-
Jul 2, 2012 03:10 PM
Barclays on AstraZeneca (AZN): Acquisition of AMLN Makes Strategic Sense but High Price Tag
-
Jul 2, 2012 02:15 PM
S&P Biotech EFT (XBI) Pops on Amylin (AMLN) Buyout News
View All Articles
-
Jun 30, 2012 09:57 AM
Bristol-Myers Squibb (BMY) Acquires Amylin (AMLN) for $31/Share
-
Jun 5, 2012 06:57 AM
Amylin (AMLN) Bidding Intensifies; Sale Expected in July
-
May 15, 2012 08:35 AM
Amylin (AMLN) Attracting a Host of Other Suitors, Shares Rise
-
Apr 26, 2012 07:06 AM
Amylin Pharmaceuticals (AMLN) Posts Narrower than Expected Q1 Loss of 23c/Share
-
Mar 28, 2012 09:35 AM
UPDATE: Amylin (AMLN) Rejected $22/Share Bid from Bristol-Myers (BMY)
-
Feb 6, 2012 04:43 PM
Amylin Pharma (AMLN) Reports Q4 GAAP Loss of $3.15/Share
-
Oct 19, 2011 04:06 PM
Amylin Pharmaceuticals, Inc. (AMLN) Posts Q3 Loss of $0.07, Sales Fall Short
-
Jul 26, 2011 07:33 AM
Amylin Pharma (AMLN) Posts Wider than Expected Q2 Loss; Revs Beat
View All Major News
-
Aug 1, 2012 07:34 AM
Bristol-Myers Squibb (BMY) Reports Waiting Period to Acquire Amylin Pharmaceuticals (AMLN) Expired
-
Jul 10, 2012 07:33 AM
Bristol-Myers Squibb (BMY) Commences $31/Share Cash Tender for Amylin (AMLN)
-
Jul 10, 2012 07:16 AM
Stocks with implied volatility movement; AMLN CVS
-
Jul 9, 2012 07:46 AM
Stocks with implied volatility below IV index mean; AMLN LNCR
-
Jul 6, 2012 04:26 PM
Top 10 News Items 7/2-7/6: Private Sector Showed Slowest Pace of Job Growth in 10 Months; Central Banks React; Mergers Get Serious on Monday
-
Jul 6, 2012 07:05 AM
Stocks with implied volatility below IV index mean; AMLN LNCR
-
Jul 3, 2012 06:49 AM
Morgan Stanley Upgrades Amylin Pharmaceuticals (AMLN) to Equalweight
-
Jul 2, 2012 05:13 PM
Market Wrap: US Manufacturing Hits the Skids; Apple Settles 'iPad' Suit; Merger Monday!
-
Jul 2, 2012 03:10 PM
Barclays on AstraZeneca (AZN): Acquisition of AMLN Makes Strategic Sense but High Price Tag
-
Jul 2, 2012 02:15 PM
S&P Biotech EFT (XBI) Pops on Amylin (AMLN) Buyout News
View All Reports